Works Cited
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.
1. Abdel-Latif ME, Pinner J, Clews S, Cooke F, Lui K, Oei J. Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers. Pediatrics. 2006;117(6):e1163-e1169.
2. American College of Obstetricians and Gynecologists. Opioid use and opioid use disorder in pregnancy. Obstet Gynecol. 2017;130(2):e81-e394.
3. American College of Obstetricians and Gynecologists. Breastfeeding challenges and substance use disorders. Obstet Gynecol. 2021;137(2):e38-e44.
4. Becker SJ, Scott K, Helseth SA, et al. Effectiveness of medication for opioid use disorders in transition-age youth: a systematic review. J Subst Abuse Treat. 2022;132:108494.
5. Chan B, Gean E, Arkhipova-Jenkins I, et al. Retention strategies for medications for opioid use disorder in adults: a rapid evidence review. J Addict Med. 2021;15(1):74-84.
6. Fouladvand S, Talbert J, Dwoskin LP, et al. Predicting Opioid Use Disorder from Longitudinal Healthcare Data Using Multistream Transformer (MUPOD) [Preprint]. Available at http://arxiv.org/abs/2103.08800. Last accessed March 5, 2026.
8. Jones HE, Kaltenbach K, Heil SH, et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med. 2010;363(24):2320-2331.
9. Reece-Stremtan S, Marinelli KA; Academy of Breastfeeding Medicine. ABM clinical protocol #21: guidelines for breastfeeding and substance use or substance use disorder, revised 2015. Breastfeed Med. 2015;10(3):135-141.
10. Schiff DM, Nielsen T, Hoeppner BB, et al. Methadone and buprenorphine discontinuation among postpartum women with opioid use disorder. Am J Obstet Gynecol. 2021;225(5):538.e1-538.e10.
11. Substance Abuse and Mental Health Services Administration. Clinical Guidance for Treating Pregnant and Parenting Women With Opioid Use Disorder and Their Infants. Available at https://library.samhsa.gov/sites/default/files/sma18-5054.pdf. Last accessed March 5, 2026.
12. Tran TH, Griffin BL, Stone RH, Vest KM, Todd TJ. Methadone, buprenorphine, and naltrexone for the treatment of opioid use disorder in pregnant women. Pharmacotherapy. 2017;37(7):824-839.
13. Wachman EM, Byun J, Philipp BL. Breastfeeding rates among mothers of infants with neonatal abstinence syndrome. Breastfeed Med. 2010;5(4):159-164.
14. World Health Organization. Guidelines for the Identification and Management of Substance Use and Substance Use Disorders in Pregnancy. Available at https://www.who.int/publications/i/item/9789241548731. Last accessed March 5, 2026.
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.